Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK14 | Q16539 | 7/20 | 0.54 |
| ▸ | KDR | P35968 | 7/20 | 0.54 |
| ▸ | KIT | P10721 | 5/20 | 0.54 |
| ▸ | CSF1R | P07333 | 3/20 | 0.54 |
| ▸ | LCK | P06239 | 9/20 | 0.52 |
| ▸ | BTK | Q06187 | 7/20 | 0.52 |
| ▸ | BRAF | P15056 | 3/20 | 0.52 |
| ▸ | SRC | P12931 | 3/20 | 0.52 |
| ▸ | SYK | P43405 | 3/20 | 0.52 |
| ▸ | ESYT2 | A0FGR8 | 2/20 | 0.52 |
| ▸ | NBAS | A2RRP1 | 2/20 | 0.52 |
| ▸ | CNOT1 | A5YKK6 | 2/20 | 0.52 |
| ▸ | TBKBP1 | A7MCY6 | 2/20 | 0.52 |
| ▸ | AGPS | O00116 | 2/20 | 0.52 |
| ▸ | MYO1F | O00160 | 2/20 | 0.52 |
| ▸ | SNAP23 | O00161 | 2/20 | 0.52 |
| ▸ | AP3B1 | O00203 | 2/20 | 0.52 |
| ▸ | PSMD12 | O00232 | 2/20 | 0.52 |
| ▸ | BMPR1B | O00238 | 2/20 | 0.52 |
| ▸ | PGRMC1 | O00264 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21942945 | 0.92 | KDR (0.48) | MAPK14KDRKITCSF1RLCK | |
| SCHEMBL21942934 | 0.90 | BRAF (0.53) | MAPK14KDRKITCSF1RLCK | |
| SCHEMBL21943333 | 0.88 | KDR (0.61) | MAPK14KDRKITCSF1RLCK | |
| SCHEMBL21943325 | 0.88 | BRAF (0.52) | MAPK14KDRKITCSF1RLCK | |
| SCHEMBL21943705 | 0.85 | BRAF (0.55) | MAPK14KDRKITCSF1RLCK | |
| SCHEMBL21944012 | 0.83 | RET (0.62) | KITCSF1RBRAFSRCABL1 | |
| SCHEMBL21943413 | 0.83 | LCK (0.67) | MAPK14KDRKITCSF1RLCK | |
| SCHEMBL21943580 | 0.81 | GGPS1 (0.51) | KDRKITBRAFPDGFRBFGFR1 | |
| SCHEMBL21943499 | 0.80 | KDR (0.59) | MAPK14KDRKITCSF1RLCK | |
| SCHEMBL22025031 | 0.80 | BRAF (0.75) | MAPK14KDRKITCSF1RLCK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11319322-B2 | Substituted aryl ether compound, preparation method thereof, pharmaceutical composition and use thereof | XIAMEN UNIVERSITY (CN) | 2022-05-03 | — | — | US | disclosed |
| EP-3647313-A1 | SUBSTITUTED ARYL ETHER COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND USE THEREOF | Xiamen University (CN) | 2020-05-06 | — | — | EP | disclosed |
| US-20200123162-A1 | SUBSTITUTED ARYL ETHER COMPOUND, PREPARATION METHOD THEREOF, PHARMACEUTICAL COMPOSITION AND USE THEREOF | XIAMEN UNIVERSITY (CN) | 2020-04-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200123162-A1 | SUBSTITUTED ARYL ETHER COMPOUND, PREPARATION METHOD THEREOF, PHARMACEUTICAL COMPOSITION AND USE THEREOF | CYP4A11, CYP2D6, CYP3A43 | MAPK14 926/4885KDR 2067/4885KIT 603/4885 |
| US-11319322-B2 | Substituted aryl ether compound, preparation method thereof, pharmaceutical composition and use thereof | CYP4A11, CYP2D6, CYP3A43 | MAPK14 926/4885KDR 2067/4885KIT 603/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.